other in Berlin's fashionable West End (Werner Mosse, personal communications). Hugh passed his childhood in a crowd of sharply remembered uncles, aunts and cousins, with wellordered arrangements for mutual entertainment and support, the whole presided over by his formidable grandmother, Therese Litthauer. The gregariousness built into his formative years was happily echoed in the spontaneous friendliness to people of every kind for which Hugh and his wife Mary were famous in later life. Nevertheless, although Hugh's reminiscences clearly show his feelings of enjoyment as well as security amongst the young cousinry, an anecdote suggests that he was also irked by it. For his sixth birthday party his mother asked him to invite his friends. Hugh had two friends but invited only one. When his mother asked, why only one, he replied 'Oh, I hate crowds!' Like his parents, Hugh was subjected to compulsory instruction in the Jewish religion during childhood. That, however, remained his only contact with religious Jewishness. His ironical attitude to traditional religion was well developed by the age of 15, when he and his sister Lotte had to decide whether to have Jewish or Christian instruction: 'We went into committee and deliberated. We decided for the Christian instruction. Basically our philosophy was that we thought the Jews would teach us the Old Testament only, but that in the Christian instruction we would have the New Testament thrown in, as it were, as a bonus. Since we were quite keen on information, we thought that was the better bargain.' In later life Hugh became close to the Society of Friends through his wife Mary who was a Quaker. Apart from that, there is no evidence that religion played a part in his thinking or feeling as an adult.
Hugh's education began quite early at a private school. From the age of nine he went to the Royal Prinz-Heinrich-Gymnasium in Berlin Schoneberg, an old-fashioned institution where teaching was based on Greek and Roman classics. In 1917, that is towards the end of World War I, Hugh left that school and worked for a year as a 'lab boy' with another friend of his father's, N. Zuntz, Professor of Animal Physiology at the agricultural college (Landwirtschaftliche Hochschule) in Berlin. Zuntz was a pioneer of high altitude physiology; indeed, Joseph Barcroft, under whom Hugh later worked in Cambridge, had his first experience of physiological research as a member of an expedition led by Zuntz to the Pic of Tenerife (see Roughton 1949) .
Following this brief physiological apprenticeship Hugh became a medical student at the Universities of Berlin and Freiburg im Breisgau. In Berlin from 1917 to 1919, he has commented that the teaching of biochemistry was not up to much; for one thing it was not a compulsory subject and was not examined in the Physikum, the examinations that terminate preclinical studies in Germany.
In Freiburg the position of biochemistry was better. There was a professorship of physiological chemistry held by F. Knoop, the discoverer of 6-oxidation of fatty acids. Knoop was a good teacher, running well-organized practicals, and ready to talk to his students about any questions they wanted to ask.
The most outstanding teacher in Freiburg was Ludwig Aschoff, the Professor of Pathology and an eminent representative of the German school of classical 'morbid anatomy'. Hugh remembers him nevertheless as a man of wide interests, always keen to relate structure and function. The 'Aschoff-Tawara' node of a mammalian heart was discovered by him, and he introduced the concept of the reticulo-endothelial system which, , is still useful. The teacher who had the most decisive influence on him was J. von Kries, who was Professor of Physiology in Freiburg and had himself been a student under Ludwig and Helmholtz. In 1920 Hugh wrote his M.D. thesis entitled 'A study of the effect of changing the osmotic pressure of the surrounding fluid on the rate of conduction of impulses in the frog's sciatic nerve' on experimental work done in Kries's laboratory.
Hugh returned to Berlin for his clinical studies in 1921. There he also attended a course of excellent lectures entitled 'Colloid chemistry' by P. Rona, himself a pupil of L. Michaelis, originator of the Michaelis-Menten equation and one of the pioneers of modem biochemistry. In Rona's lectures Hugh for the first time came across notions such as pH, isoelectric point and many others basic to modem biochemistry. Two years later he passed the final professional examination in medicine in Berlin and after a further two years obtained the M.D. degree from Freiburg University with highest honours (summa cum laude).
C a r e e r b e g i n n i n g s Hugh began his working life in January 1923 in the University Clinic for Internal Medicine in Gottingen. He described his Professor, Erich Meyer, as a most inspiring teacher, who died tragically in the Alps shortly after Hugh left. In the autumn of 1924 Hugh went to Davos with Adolph Loewy, the Director of the Physiological Laboratory there, for work subsequently published in Pflliger's Archiv. That time brought Hugh's first introduction to pharmacology as a separate science, when he attended a meeting of the German Pharmacological Society in Innsbruck. There, Professor J. Geppert from Giessen demonstrated with goose erythrocytes how cyanide inhibits cellular respiration, remembered by Hugh probably because he himself did some experiments on this after joining Meyerhof in the following year.
In January 1925 Hugh returned to Berlin to join Otto Meyerhof at the Kaiser Wilhelm Institute for Biology, where he stayed until the end of 1932. This invaluable research apprenticeship with the famous Meyerhof was interrupted for a year in 1926 when Hugh went down with pulmonary tuberculosis, at that time a very serious illness indeed for which, unlike now, there were no effective drugs. The measures then available, well described in The Magic Mountain by Thomas Mann, fortunately helped Hugh to make a good recovery. However, the same illness reappeared, as was its wont, on two later occasions, laying him low for nine months in 1932-33 and again in 1944-45 . This appears to have been the only major illness he suffered until towards the end of his life; and happily neither the length nor the productivity of his life was diminished by this greatly feared disease.
In 1928 Hugh left Meyerhof to become Assistant in Physiology at Jena University where he spent a year. Then came a major break with Meyerhof's invitation of a position in his new Institute in Heidelberg, which Hugh was of course gratified to receive and to accept. Hugh regarded his time in Meyerhof's laboratory as an apprenticeship, with little in the way of intellectual contribution from himself. When asked later why Meyerhof supported him for so long although they published so little together Hugh replied, with a twinkle in his eye, 'I think it was because he liked me!' Hugh also thought that he was not assertive enough, with the result that he did not develop his own line of research until rather late. When he did, he drew heavily on the work on non-enzymic oxidations he had done in Meyerhof's lab.
While the Institute was being staffed and equipped Meyerhof sent Hugh for the year 1929-30 to work with A.V. Hill, the other leading muscle physiologist, at University College, London. On Hill's advice he spent both summers at the Marine Biological Laboratory in Plymouth, where he and two co-workers discovered the 'Blaschko, Kattell and Kahn Effect', a facilitation phenomenon in the crustacean claw. For the first time Hugh experienced the thrill of independent discovery, but, with characteristic modesty, he referred to this later as a modest contribution and gave great credit to the beautiful analysis of the effect carried out by Pantin (1936) . When Hugh was on a visit to Harvard in 1954, his friend John Welch, Professor of Zoology there, laid on a demonstration of the effect as a class experiment for his students. Hugh was pleased that the observations, made some 25 years earlier, had remained valid and relevant.
The period with Otto Meyerhof brought Hugh in contact with many talented people who subsequently became leaders in the biomedical sciences; they included R.W. Gerard, F. Lipmann, K. Lohmann, E. Lundsgaard, A. Lwoff, K.H. Meyer, A. von Muralt, D. Nachmansohn, S. Ochoa and F. Schmitt. Under the same roof in Dahlem there worked Otto Warburg, and there Hugh met again H. Krebs, whom he had first known in 1919 as a fellow medical student in Freiburg. With most of these outstanding contemporaries Hugh formed lifelong friendships.
C h a n g e o f c o u n t r y
In his autobiographical letters to Werner Mosse, Hugh says that, although he might have had occasional slight difficulties with getting jobs because of being Jewish, it never gave any serious trouble before the rise of National Socialism. This changed for him, as for so many others, when Hitler became Chancellor of Germany in the spring of 1933.
Fortunately for him, Hugh never experienced Hitlerism directly. For the last few months in Germany he was a hospital patient in Freiburg. Baden was a land where Nazi flags and uniforms had been forbidden until the autumn of 1932, and he entered the hospital at just about the time when these symbols appeared. The environment in which Hugh had lived in Germany contained a large proportion of assimilated Jews similar in background and outlook to his own. The Hitler experience certainly made him more aware of his Jewishness, but by the time this experience came his way he was already too formed in outlook and ideals to be fundamentally affected.
Hugh left Germany and came to England for good in May 1933, brought here under the aegis of the Academic Assistance Council. The Council had been set up by a number of prominent people, including Archbishop Temple and Sir William Beveridge, for the purpose of aiding scholars arriving as refugees in Britain; and it was run by prominent British academics, amongst them Professor A.V. Hill, with whom Hugh had worked in 1929-30. This was a fortunate connection, and made the circumstances of his emigration more favourable than those of many contemporaries and friends. During his first year in England he lived in London with one of his aunts, Lene Nauheim, and did little scientific work. He spent most of the time assisting A.V. Hill on the Academic Assistance Council in looking after German scientists who were arriving as refugees (see Katz 1978) . Hugh said later that he learnt from Hill that a scientist's duty is not limited to the laboratory but extends to the care and support of the people around him, as he himself was to do throughout his life.
The connection with the Academic Assistance Council lapsed for a while when Hugh moved to Cambridge in 1934, although his advice continued to be sought in relation to particular people whom he knew about. The connection was re-established at the start of the War, when the Academic Assistance Council became the Society for the Protection of Science and Learning, with offices in Cambridge. On the suggestion of A.V. Hill the Home Office arranged for the vetting of interned refugee academics by tribunals set up for this purpose; and by submitting dossiers to the tribunals Hugh Blaschko helped many valuable colleagues to regain their freedom and play their part in the British war effort.
One other anecdote from this period is worth recalling, namely the plan to transplant Blaschko, Krebs, Nachmansohn and Rothschild to Israel to form the nucleus of a new scientific research institute at the Hebrew University. Although there had been an offer of funds the plan came to nothing, possibly because of opposition from Chaim Weizmann who was setting up the Institute named after him in Rehovot and was probably not too keen on a rival institution in Jerusalem. Apparently, Weizman liked Hugh very much but thought him too 'assimilated' for Israel.
C a m b r id g e In 1934 Hugh Blaschko moved to Cambridge on the strength of a recommendation from A.V. Hill to Sir Joseph Barcroft, who became his host in the Physiological Laboratory. Now Hugh found himself again in a first-class research environment and quickly settled down to work, mainly using the Warburg manometric apparatus he had brought with him from Germany. One of his uncles, still a director of a chemical factory in Germany, presented Hugh with a collection of about 50 little bottles of chemicals, mostly amino acids and amines, a priceless gift which later accompanied him to Oxford. The only research money was a one-year grant from an American charitable foundation, with which he paid a laboratory assistant. For the first two years in Cambridge Hugh lived on a very modest grant from the Academic Assistance Council. When that came to an end in 1936, and for almost a decade thereafter, he had no fixed income, living on money earned from demonstrating to practical classes in the laboratory, and from occasional lectures. In addition he soon began to take on students, mainly medicals, from several Colleges for supervision. In 1938 one of Joseph Barcroft's former colleagues, Douglas Barron, became a tutorial Fellow at St John's College and asked Hugh to take on the supervision of all his physiology students. This provided a modest but reasonably assured income, but also a good deal of additional work. Although during term there was little time for experiments Hugh remembered it as very enjoyable and retained vivid recollections of his students, some of whom, like Fred Sanger and Eric Denton, achieved high distinction. When, with the outbreak of war, Barron, an American citizen, had to return home, Hugh acted as Director of Medical Studies at St John's. Aware of the insecurity of his position, Hugh applied for job vacancies as they came up. He later wondered whether his lack of success might have had to do with the bouts of pulmonary tuberculosis in his medical history. These worries never stopped him doing research; and he found comfort in the support of senior colleagues, chief among them Joseph Barcroft and David Keilin.
Cambridge formed the background of Hugh's first consistent experience of English life. To quote Bronowski (1973) in The Ascent o f Man: 'Ancient University towns are wonderfully alike'; and Hugh, having lived in Freiburg, as well as being friendly and adaptable, did not take long to become accustomed to the very English environment of Cambridge. Just occasionally he commented wryly on the reserve bordering on coolness of some English people, such as the distinguished senior colleague working in the same Department who never spoke to Hugh until the day he was run over by this man on his bicycle, when he had to apologize.
In later years Hugh came to regard his decade in Cambridge as the most important period in the development of his scientific interests. He came to Cambridge without any fixed plan about the direction his work was to take. But within a year of coming to Cambridge he had found an area of research that was novel and rewarding, and which became the starting point for his dominant research interests. One Cambridge contemporary whom Hugh later remembered as having been particularly influential on his scientific development was Wilhelm Feldberg. They had become friendly in 1933 when both were in London; and Hugh had been excited by Feldberg's pioneer work on neurotransmission. In the autumn of 1938 Feldberg joined the Physiology Laboratory in Cambridge. Hugh has described that as a very fortunate event because from then on he had an almost daily exposure to the new ideas that were developing in the field of neurohumoral transmission. Their way of looking at these problems was different. Feldberg's approach was physiological while Hugh's was strongly influenced by his biochemical background; but he was very much aware of the value of their constant discussions, often in the warm and generous hospitality of the Feldberg's home.
Early in 1944 Hugh moved from Cambridge to Oxford, where the Professor of Pharmacology, J.H. Burn, was interested in his work, about which Hugh had informed him on occasional visits. In the autumn of 1943, during a vacation with his Oxford friends Arthur and Ilse Cooke, Hugh had taken the opportunity to look in on Bum one Saturday morning. In the course of conversation Hugh mentioned having just applied for a job in New Zealand and asked Bum what he thought about this. Bum was evidently surprised because he seemed to believe that Hugh was well settled in Cambridge. However, when told about the uncertainties there, Bum encouraged him to apply for every job that was going. Back in the Cambridge laboratory on the Monday morning Hugh found a letter from J.H. Burn with the offer of a place in the Oxford department, and a promise of a permanent university post at the end of the war.
Hugh was immediately attracted by B um 's offer and was also advised to accept it by his senior colleagues Joseph Barcroft and David Keilin. So he arrived in Oxford in early 1944, remained there for the rest of his life, and never had any reason to regret having done so. Tme to his word, Bum got Oxford University to appoint Hugh a senior research officer in the Department of Pharmacology in 1946. Hugh held this appointment until 1965 when he became Reader in Biochemical Pharmacology, until his retirement in 1967.
Arriving in Oxford was quite an experience for Hugh, because the working environment was very different from that in Cambridge. There, the individual laboratories and their inhabitants in the Physiology Department had very little contact with one another. Even the daily coming together for tea ceased when the war began, although Hugh and Feldberg still had tea together almost daily somewhere along King's Parade. In the Oxford Pharmacology Department there was much more cohesion, and through daily lab. lunches in the library all were kept informed about what everyone was doing. For Hugh this had the additional advantage of an informal, continuing introduction into pharmacology at a very high level. As well as the Professor there were other distinguished members of staff, notably Edith Bulbring (F.R.S.) who was foremost in the electro-pharmacological analysis of smooth muscle; Raymond Ing (F.R.S.), whose structure-activity analyses contributed crucially to modem chemical pharmacology; and Miles Vaughan Williams, well known for his contributions to the pharmacology of cardiac arrhythmias. And in 1960 Burn was succeeded in the Chair by W.D.M. Paton (later Sir William Paton, F.R.S.), an outstanding scientist who had already made his mark in the pharmacological world by his rate theory of drug action and the elucidation of ganglionic and neuromuscular block.
Another difference from Cambridge was, that from the beginning Hugh had co-workers. The first of these was Ruth Duthie, a biology graduate from Trinity College, Dublin. Ruth's husband, Edward Duthie, was a member of Howard Florey's penicillin team. Ruth, who assisted Hugh for about a year, proved invaluable towards the end of 1944 when another bout of pulmonary tuberculosis took him away from the lab. for about nine months. During that period Ruth came almost daily to the Osier Pavilion, where Hugh was a patient, to discuss her results and tomorrow's work. Ruth was succeeded by Isabel Wajda, a war refugee from Poland, but by the end of 1945 Hugh was himself back at work.
He soon realized that the days when he did the experiments himself were over. Instead, he recruited a succession of laboratory technicians, most of them girls who stayed for only one year. He took great care of the technicians. If any of them showed the slightest sparkle, they were encouraged to study for a degree, and several of them went on to do doctorates and to become independent scientists. One of these was Jean Himms, who joined Hugh straight from Milham Ford School, a few days before her sixteenth birthday. She proved to be a girl of exceptional ability, not only in her scientific work but also in organizing the laboratory so as to enable Hugh to accept more visitors. Bum had allocated Hugh a spacious laboratory which, although increasingly congested, Hugh liked and retained until the early 1960s. In the mid1950s he also inherited the rooms vacated by Janet Vaughan, doubling the space at his disposal. Jean Himms's quiet efficiency helped to ensure optimal use of every available comer so that everyone's work, including her own, could proceed effectively. When Jean left after eight years she became a Fellow of Harvard College, was subsequently elected into the Fellowship of the Royal Society of Canada, and is now Professor of Biochemistry at the University of Ottawa. In 1956 Jean married another co-worker of Hugh's, Paul Hagen, who had come to the laboratory from Australia at the end of 1952 as a Charles Martin Research Fellow.
From the end of the War Hugh was joined by co-workers in increasing numbers. The first graduate student was Gerald Sloane Stanley who worked with Hugh and with Pamela Holton on decarboxylases. They were followed by collaborators of all seniorities, from research students working for their Oxford D.Phil. to well-known professorial colleagues from Britain and abroad. Their names appear in the science part of this memoir and on his publications. All praised the benefit and pleasure of working and being with him.
With his many co-workers Hugh retained close personal relations, although there were inevitably great divergences in the directions of their later work. There was no continuity between what Jean Hagen had done in Blaschko's laboratory and her later research on brown adipose tissue. Arnold Welch, already head of the exceptionally large and distinguished Pharmacology Department of Yale, came as a Senior Fulbright Research Fellow in 1952. In their first joint experiments they ran into the observation that adrenaline and noradrenaline are held in chromaffin tissue in a distinct type of cell organelle, which are now called the chromaffin granules. This discovery determined much of Hugh's subsequent research. The immediate consequence of the collaboration was that Arnold Welch invited Hugh and his wife to join him at Yale, where they continued the work in the autumn of 1953. Some time later Arnold began to move into the higher echelons of scientific administration, as President of the Squibb Research Institute in Princeton, where his research interest returned to his original field of cancer chemotherapy. The localisation of 5-hydroxytryptamine in mucosal granules similar to the chromaffin granules was discovered during her D.Phil. work by Ruth Baker who, soon thereafter, turned towards part-time sub-editing for the Journal of Neurochemistry because of family obligations.
Other students later continued and very successfully extended the work they had done with Hugh, including Peter Banks, who became Biochemistry Professor in Sheffield; Franca Buffoni, Pharmacology Professor in Florence; Karen Helle, Professor of Physiology in Bergen; David Smith, Professor of Pharmacology in Oxford itself; and Hans Winkler, Professor of Pharmacology in Innsbruck. Oleh Homykiewicz arrived in Oxford in 1956 at a time when Hugh was considering the possibility of a regulatory function for dopamine, about which nothing was known at the time. Oleh made some interesting observations on its blood pressure effects, but his great contribution to present-day knowledge of dopamine came after his return to Vienna, where he discovered the relationship between dopamine and Parkinson's disease. Hornykiewicz became Professor of Pharmacology in Vienna, and his discovery resulted in the first effective drug treatments for this disabling disease. Warburg's laboratory before World War I and still, in the early 1920s, worked occasionally on topics within Warburg's field of interest. As a result of that influence Blaschko's first paper from Dahlem concerned the reversibility of cyanide inhibition of various model respiratory systems including oxidation of amino acids by charcoal and decomposition of hydrogen peroxide by palladium black. Familiarity with cyanide inhibition of autoxidations was to be of major significance when he came to study adrenaline breakdown twelve years later.
Even without interruptions through illness, it is doubtful whether Blaschko could have developed an independent programme of research in Meyerhof's laboratory where his primary task was to provide thermometric and calorimetric services rather than to contribute original ideas. That technical role is reflected in an article on microcalorimetry published in Oppenheimer and Pincussen's compendium on 'The enzymes and their action' in 1928 and by a tabulation of data on 'The energetics of contraction by cross striated muscle' in W. Junks's Tabulae Biological Periodical of 1934. There was one major paper with Meyerhof and Lundsgaard in 1933 concerning the energetics of muscle contraction during inhibition of lactate production in which it was shown that the heat of hydrolysis of creatine phosphate and adenosine triphosphate accounted for some 80 per cent of heat production that could be attributed to contraction. He also produced a brief paper on the reality of delayed anaerobic heat production by stimulated muscle during his visit to Hill in 1930.
Whilst in Jena, Blaschko published on the mode of action of cardiac nerves in fish but the work he regarded as his first really original contribution came about from a visit to the Marine Biological Laboratory in Plymouth in the summer of 1929 and 1930. It concerned the effect of stimulation frequency on the nature of the contraction evoked from the adductor muscle of crustacean claws, a phenomenon now known as the Blaschko, Cattell and Kahn effect. These two papers are early hints of Blaschko's interest in comparative studies and his enthusiasm for opportunities afforded by marine biological laboratories. It was entirely appropriate that his last piece of experimental work was carried out on chromaffin tissue from Myxine Glutinosa L. obtained from the Biological Station at Espergend in Bergen whilst visiting Norwegian friends and colleagues in 1972.
Before he left Germany permanently in 1933 Blaschko was clear that he wished to be a biochemist rather than a biophysicist and had written to Hill to that effect. So it was arranged that he should go to work in the pathology laboratory of University College Hospital headed by Professor H.E. Boycott rather than with Hill. That he later chose to go to the Physiology Department in Cambridge under Barcroft rather than to Hopkins seems strange but was at least in part occasioned by M eyerhof's opinion that biochemical and biophysical investigations should not be separated from mainstream physiology. In that view, Meyerhof differed from Hopkins whom Blaschko had heard argue strongly for Biochemistry as a distinct discipline at the 12th International Congress of Physiology in 1926. That Meyerhof chose in 1929 to call his new institute in Heidelberg Institut fur Physiologie was not without significance.
From his earliest days in Dahlem, Blaschko was familiar with Warburg manometers and he refreshed his skill with them in 1933 under the supervision of Hans Krebs who was one of his physicians during convalescence in the Medical University Clinic in Freiburg. On leaving Germany he purchased the Warburg manometer bath and manometers that accompanied him to England and served him faithfully for about 20 years. At that point Blaschko became, and to a large extent remained, an enzymologist who used manometry to study enzyme-catalysed reactions.
Cambridge
In 1934 the relationship between catalase and cellular respiration was unclear. Blaschko saw there was a problem which his experience and technical resources would allow him to attack. He began by investigating the reversibility of catalase inhibition. For that work he designed a manometer flask with two side bulbs branching from a single stem. The reaction was started by mixing the contents of the side bulbs which included inhibitor, enzyme and substrate. It was allowed to continue for 5 to 10 minutes before the reacting mixture was tipped into the main compartment which action, depending on the presence or absence of inhibitor, had the effect of maintaining or diluting the inhibitor concentration. By this simple expedient the reversibility of inhibition could be tested easily.
That line of research was brought to an abrupt halt by Joseph Barcroft asking whether Blaschko knew how adrenaline was destroyed in the body. He did not, so went to the library to look up the answer but found that it was not known. Curiously, at about the same time, Gowland Hopkins suggested to Derek Richter in the Biochemistry Department that he might like to investigate the same topic. From these chance conversations arose the remainder of Blaschko's scientific work.
Discovery of amine oxidase
Barcroft's question stimulated Blaschko's interest for several reasons. He had read that adrenaline underwent 'autoxidation', and he was familiar with such reactions. Furthermore, he had heard Otto Foewi talk about vagus and accelerans substances at meetings in 1924 and 1926 and had followed discussions of chemical transmission at nerve endings at meetings of the Physiological Society in the 1930s. Thus he was aware that, in addition to being a hormone, adrenaline might also be the transmitter substance released from the endings of post-ganglionic sympathetic neurones. Finally, methods to confront the problem were at hand in the form of manometry and the bioassay skills of Hans Schlossmann with whom he shared a laboratory.
Preliminary experiments showed that extracts of rat liver, Warburg's 'Komchensuspension', accelerated inactivation of adrenaline in the presence of oxygen, but the stoichiometry of the process was obscure. Autoxidation required two to three atoms of oxygen per molecule of adrenaline to reduce pressor activity by half, whereas only one atom of oxygen was used to achieve the same effect in the presence of tissue extract. At that stage of the investigation Derek Richter joined the group as a result of a conversation with Hans Krebs who also worked in the Department of Biochemistry and with whom Richter had previously shared lodgings. The definitive paper arising from that collaboration was published at the beginning of 1937. It showed that when autoxidation was inhibited by cyanide only one molecule of oxygen was consumed per molecule of adrenaline destroyed, and that with ferric chloride the reaction product gave the green colour characteristic of catechols. The reaction products were shown by Richter to be an aldehyde and the methylamine heat-sensitivity, non-dialysability and sterospecificity indicated that the process was enzyme-catalysed whilst inhibitor studies and the ferric chloride test ruled out an involvement of catechol oxidase. The authors called their newly discovered enzyme adrenaline oxidase. In a further paper that year Blaschko and colleagues showed that their preparation was able to oxidize other amines including aliphatic amines and tyramine. A few months earlier Pugh and Quastel had described an aliphatic amine oxidase and Richter knew that a tyramine oxidase, apparently unable to oxidize adrenaline, had been described nine years previously in Hopkin's laboratory by Hare. The conclusion drawn from inhibitor and competition experiments as well as from distribution studies was that the three enzymes were identical and distinct from both amino acid decarboxylase and histaminase. The enzyme was therefore renamed amine oxidase and numerous compounds were tested for their ability to act as substrates From the earlier work it was already apparent that the enzyme could act on both primary and secondary amines. In the discussion section of the paper the authors suggested that amine oxidase, which was especially active in liver and intestine, protects the body from toxic amines present in the gut but, whilst they were confident that it played a part in destroying adrenaline introduced into the circulation experimentally, they were less sure about its capacity to deal with low levels of adrenaline under physiological conditions. Those ideas were developed in a later paper by Bhagvat, Blaschko and Richter who concluded that the enzyme may have a general function in cell metabolism but was probably not involved in destroying adrenergic transmitter released on nerve stimulation. It was to be many years before that role was established unequivocally.
Adrenaline biosynthesis
In 1938 Holtz, Heise and Ludtke described an enzyme able to decarboxylate l-(3-4)-dihydroxyphenylalanine (1-dopa) and suggested that it and amine oxidase could provide a general route for deaminating amino acids. At that time the pathway via transaminases and glutamate dehydrogenase was unknown. Blaschko was not in favour of the scheme proposed because he found that not only phenylalanine, tyrosine and histidine failed to be decarboxylated but likewise N-methyltyrosine and N-methyldopa. Instead he proposed that the enzyme might be involved in forming adrenaline. Because it had such a restricted substrate specificity, he argued that decarboxylation would have to follow introduction of the second phenolic group but precede N-methylation. As a consequence the pathway must be via a primary amine like oxytyramine (dopamine) or noradrenaline. Noradrenaline and dopamine had not then been found in animal tissues although Barger and Dale in 1910 had drawn attention to primary catecholamines having more powerful motor effects than secondary amines, and Bacq in 1934 had suggested that noradrenaline might be Cannon's sympathin E. (Actually Bacq's favoured view was that sympathin E was an oxidation product of adrenaline, but Blaschko and Schlossmann were able to show that not to be so during their investigation of amine oxidase).
The stage in the pathway at which the side chain is hydroxylated remained unknown until a sample of dihydroxyphenylserine (DOPS) was synthesized by Dalgliesh and Mann in 1947. After initial failure Blaschko and colleagues were able to show that it was slowly decarboxylated and converted to noradrenaline but at such a low rate that it was unlikely to be the natural precursor of noradrenaline. It was clear therefore that dopamine had to be the immediate precursor of noradrenaline. U.S. von Euler had discovered noradrenaline in extracts of spleen in 1945 and six years later Goodall in von Euler's laboratory found dopamine in sheep adrenal glands. The final link in the chain was inserted when Edith Bulbring in Oxford showed that noradrenaline could be converted to adrenaline by minced chromaffin tissue in the presence of adenosine triphosphate.
Interestingly, Blaschko's last paper in 1988 was a comment on observations by several clinicians that DOPS could act as an effective precursor of noradrenaline when administered to patients who lacked dopamine-6-hydroxylase, the enzyme which converts dopamine to noradrenaline, and suffered in consequence severe orthostatic hypotension.
Within three weeks of dispatching his major paper on 1-dopa decarboxylase to the Journal of Physiology in 1942, Blaschko reported in the Biochemical Journal his discovery of a closely related enzyme l(-) cysteic acid decarboxylase, thereby explaining how taurine could arise from cysteic acid, an oxidation product of the amino acid cystine.
Wartime teaching responsibilities had an adverse impact on his research output, but he was able to complete a well-researched chapter on Enzyme Systems of Cells with W. Jacobson and to write up some work on amine oxidase in Sepia Officinalis carried out at the Station Maritime in Arcachon before the outbreak of war. Further development of his interests in amine oxidases, amino acid decarboxylases and catecholamine formation had to await his move to Oxford and the end of the war.
Oxford
Blaschko arrived in Oxford with an established reputation that brought a constant stream of foreign visitors and research students to his laboratory. Those two groups were ably assisted by a succession of excellent technicians. Between 1944 and his official retirement in 1967 he published 190 papers and reviews, and a further 90 emanated from his laboratory that did not carry his name but which frequently owed much to his input. Two topics dominated the period, amine oxidases and storage of physiologically active amines.
More amine oxidases
In 1937 lack of inhibition by cyanide had served to differentiate amine oxidase from histaminase the only other enzyme known at that time to oxidize a biogenic amine. Both of those are intracellular enzymes. Joyce Hawkins in Blaschko's group and Cortzias and Dole independently demonstrated that monoamine oxidase is located in mitochondria. Those observations implied that, in contrast to the extracellular termination of acetylcholine activity by acetylcholinesterase, inactivation of catecholamines must be preceded by their uptake into cells. At a meeting in honour of Otto Loewi at Philadelphia in 1953, Blaschko discussed the possibility that some drugs, for example cocaine, which potentiate actions of catecholamines might competitively block amine uptake into cells and thus deny their access to amine oxidase rather than inhibit the enzyme directly. That inspired suggestion was to be fully vindicated by the work of Bum, Iversen, Trendelenburg and others in the 1960s. Of course when Blaschko made his remarks the only site for which the intracellular location of amine oxidase was known was liver. The significance of mitochondrial amine oxidase in noradrenergic nerve endings was not appreciated until some years later.
Blaschko and co-workers examined the substrate and inhibitor specificities of amine oxidase and histaminase in considerable detail in the 1950s and extended their studies to plasma enzymes after the discovery of spermine oxidase by Hirsch in 1953. That enzyme behaved much as amine oxidase in many respects except that it was inhibited by cyanide and other carbonyl reagents. They found that whilst spermine oxidase is present in blood plasma from ruminants it is absent from that of non-ruminants. The latter, however, possessed an enzyme able to oxidize benzylamine and which, like spermine oxidase and histaminase, was sensitive to carbonyl reagents. That discovery was the impetus to carry out an extensive study of the distribution and characteristics of the plasma oxidases in mammals which involved collaboration with many zoos and research institutes. It was confirmed that spermine oxidase is confined to ruminants and some animals, including hippopotamus and hyrax, whose guts have rumen-like features; whilst benzylamine oxidase is present in many carnivores, some primates, the horse and non-ruminating artiodactyla such as pigs. Blaschko suggested that spermine oxidase evolved from benzylamine oxidase together with the ruminant style of life and provides protection against polyamines formed by fermentations occurring in the rumen.
Benzylamine oxidase was crystallized by Buffoni and Blaschko and shown to contain both copper and pyridoxal phosphate. They also demonstrated that the purified enzyme was able to act on histamine as well as on benzylamine. The role of benzylamine oxidase is unknown but Buffoni and Hope demonstrated immunological cross-reaction between pig plasma benzylamine oxidase and blood vessels, connective tissue and tendons in piglets at a stage of development when Blaschko and Hawes had found that the plasma enzyme had yet to appear. Those observations have to be seen in the context of both a copper-dependent oxidase in such tissues which is involved in establishing cross links in elastin and collagen fibres and of an inhibitory effect of lathrogens on benzylamine oxidase.
Largely through Blaschko's work the cyanide-sensitive amine oxidases have been shown to act only on primary amines whilst the mitochondrial enzyme accepts secondary amines as well. That limitation he ascribed to the presence of pyridoxal phosphate in the former group which forms a Schiff's base with primary but not with secondary amines. During the period that he was characterizing the mammalian enzymes, Blaschko continued to examine the amino acid and amine oxidases of invertebrates during enjoyable visits to the Marine Biological Laboratory in Plymouth with his young co-workers.
Dopa decarboxylase and amine storage
In the late 1940s Blaschko and members of his laboratory turned their attention to dopa decarboxylase and found inter alia that enzyme activity declined in pyridoxin deficient rats but could be restored in vitro by addition of pyridoxal and ATP. A little later Hans Langemann, a Swiss visitor, showed that extracts of adrenal medulla decarboxylated dopa at a high rate. That observation was the unexpected point of departure for all the work on storage and secretion of biogenic amines carried out in Blaschkos laboratory from 1953 onwards.
In order to study enzymes responsible for catecholamine biosynthesis in adrenal medullae, it was deemed necessary to obtain homogenates from which pressor amines had been largely eliminated. Blaschko and Arnold Welch decided to do that by dialysing homogenates against a solution containing polyphenol oxidase from mushrooms. To their surprise the stratagem was unsuccessful and they were forced to conclude that some diffusion barrier was present within the homogenate which held back a major part of the pressor amines. They, therefore, decided to study the distribution of catecholamines within medullary homogenates by means of differential centrifuging. After an homogenate in isotonic sucrose had been freed from unbroken cells and nuclei by low-speed centrifuging, the supernatant fluid was centrifuged at 20 OOOxg for 30 to 45 minutes. Only 10 to 30 per cent of the pressor activity was recovered in the resulting supernatant fraction. The remainder could be released from the sediment by treatment with acid. Intravenous injection of resuspended particles into an atropinized spinal cat evoked a pressor response equal to only 20 per cent of their total content of catecholamines. Those observations indicated that the bulk of pressor amines in adrenal medullary cells is contained in cytoplasmic particles with sedimentation properties resembling mitochondria. Similar observations were made at the same time by Hillarp and Nilson in Sweden.
In a further paper with Paul Hagen and Welch it was noted that the large granule fraction consisted of an upper yellowish-white layer and a lower brown layer and that the latter had a higher weight ratio of pressor amine to protein than the former. By contrast the upper layer was richer in succinoxidase activity than the lower. They surmised that two populations of particles were present and that the lower population contained 12 to 17 per cent of their dry weight as pressor amines at a molal concentration of al least 0.29. The implication was that in order to maintain osmotic equilibrium the amines would have to be present in a bound form because the store remained intact in the absence of an active process. Following discovery by Hillarp, Hogeber and Nilson of large amounts of ATP in the large granule fraction, Blaschko, Bom, DTorio and Eade showed that ATP was concentrated in the amine-rich particles, and they suggested that the negative charges of ATP are concerned in binding catecholamines. Suspensions of large granules in 0.3M sucrose were centrifuged over a solution of 1.5M sucrose. Material collecting at the boundary contained little of the amines and of ATP, in contrast to the sediment. That experiment gave rise to a definitive series of experiments by Blaschko, Hagen and Hagen in which large granule fractions were centrifuged over density gradients extending from 1.6 to 2.25M sucrose. These showed that mitochondrial succinoxidase activity separated distinctly from chromaffin granules containing catecholamines and ATP. The authors were able to relate their observations to Lever's demonstration that chromaffin cells contain both mitochondria and strongly osmiophilic granules bounded by an outer membrane. Subsequently with Prusoff, Ord and Stocken, Blaschko showed that ATP in chromaffin granules was much less metabolically active than in mitochondria. That of course fitted very well with its postulated role in a storage complex. Both Eade and Schumann in Blaschko's laboratory found noradrenaline to be stored in denser granules than adrenaline, a finding in accord with the demonstration by histologists that there are two types of cell in adrenal medullae, one containing adrenaline and the other noradrenaline.
Those discoveries in the adrenal medulla inspired other similar investigations. Blaschko's research student Ruth Baker showed that 5-hydroxytryptamine in enterochromaffin cells of the small intestine is contained in granules distinct from mitochondria, and later Prusoff found that the particles contain ATP at a molar ratio of amine to ATP of about 3. Paul Hagen found histamine in dog's liver to be located in the large granule fraction, and Blaschko, Baker and Born succeeding in isolating particles from blood platelets containing both 5-hydroxytryptamine and ATP. In 1960 Baker, Blaschko and others reported that melanin granules rich in tyrosinase were quite distinct from mitochondria in a mouse melanoma.
During the 1960s attention turned to the soluble proteins present in the matrix of chromaffin granules which are released together with catecholamines and ATP by osmotic shock. Blaschko and Helle demonstrated that the sedimentation characteristics of the main component, subsequently called chromogranin A, were altered in the presence of ATP, Mg2+ and catecholamines; work by Helle and by Smith and Winkler found that the protein was acidic, contained a high proportion of proline and existed largely as a random coil. Experiments by Banks and Helle and by Schneider, Smith and Winkler revealed that the soluble matrix proteins were secreted by stimulated adrenal medullae together with catecholamines thereby providing compelling evidence for secretion by exocytosis. That is by fusion of granule and cell membranes to allow the contents to pass into the extracellular space. Such a process had been proposed by de Robertis and Vaz Ferreira on the basis of electron micrographs of resting and stimulated adrenal medullae.
Therapeutic significance
Hugh Blaschko did not discover a single therapeutic agent nor did he set out to do so but it is generally recognized that he prepared much of the ground from which arose a remarkable crop of useful drugs in the third quarter of the twentieth century. Knowledge of catecholamine synthesis was exploited to provide compounds active against hypertension. Dopa decarboxylase was the first target and a-methyldopa was introduced as an inhibitor. The success of the drug stemmed not only from its competitive inhibitory action but also from its slow conversion by the enzyme to a-methyldopamine and hence to a-methyl-noradrenaline which is stored as a false and less effective transmitter. In view of the slow rate of formation of a-methyldopa, it is surprising that a-methylnoradrenaline is stored to any great extent. That it is, is a consequence of a-methylated amines not being attacked by amine oxidase.
Monoamine oxidase inhibitors were used at the beginning of the modem era of treating depressive illness and the recent introduction of moclobemide which is reversible in action and without the side effects of the older compounds may herald a return to that form of treatment. Other antidepressants such as the imiprimine group inhibit amine uptake into nerve endings.
By setting Oleh Hornykiewicz to work on dopamine during his stay in Oxford in 1956 and drawing his attention to its recently discovered presence in the brain, Blaschko pointed out the path that led Hornykiewicz to the discovery of the beneficial effect of 1-dopa in sufferers from Parkinson's disease. The ability of 1-dopa and related compounds to pass the blood-brain barrier and reawaken reserpinized rats was studied by Blaschko and Tadeus Chrusciel in 1959. About four weeks before Homykiewicz visited him again in 1960, Blaschko had just sent the paper describing the experiments with Chmsciel to the Journal o f Physiology. It was on that visit to Oxford, while correcting the proofs of his paper on the low levels of dopamine in post mortem brains from Parkinsonian patients, that Hornykiewicz thought of the possibility of replacing the missing amine by administering its precursor dopa.
These examples, like that concerning DOPS mentioned earlier, show clearly that Blaschko's ideas and his unravelling of fundamental processes have provided a springboard for far-reaching developments in clinical medicine. M a r r i a g e Hugh Blaschko's annus mirabilis was undoubtedly 1944, the year of his arrival in Oxford and also the year of his marriage to Mary Douglas Black on 29 December. His wife was bom in Edinburgh the daughter of John Robert Black of Yelverton, South Devon, and his wife Jane (nee Begg). Mary's father, of Aberdeenshire yeoman farmer stock, worked in a mercantile firm in India, where his daughter spent most of her early years. Mary's mother was also of Scottish descent from Ayrshire and Peebles; she was born in India the daughter of the head of a missionary college.
At the time of their marriage Mary Black was a highly respected and much loved teacher at the Dragon School. There she taught many able boys whose later careers she followed with affectionate insight and pride. She had a house in Oxford's elegant Park Town, into which Hugh moved on their marriage, where they lived for the rest of his life, and which has remained Mary's home. The atmosphere was settled and very comfortable. The hall had Hugh's many hats; the drawing room a grand piano and a charming early nineteenth century family painting; the all-purpose den a mantelpiece covered with invitations; and the small garden exquisite flowers.
The Blaschko's marriage was one of extraordinary harmony, mutual support and happiness. They had no children. Instead, from the beginning their house was open to their many friends and especially to Hugh's students and co-workers. In this way, for half a century, the Blaschko home was a home-from-home for innumerable people, young and old. Together Hugh and Mary provided hospitality and encouragement for scientific shop-talk in an atmosphere of warmth and friendship. Everyone engaged in scientific research knows how important this is for the successful furtherance, not to speak of the enjoyment, of one's work. R e t i r e m e n t Hugh retired from his university appointment in 1967. For two more years thereafter the Medical Research Council provided him with a grant and the nearby Microbiology Unit with bench space, enabling him to continue doing experimental work through visitors. He continued to have a small writing comer in the Pharmacology Department. As was to be expected, Hugh remained keenly interested and involved in the scientific developments arising out of his discoveries and in the personal progress of his collaborators and of their many friends. They continued to have open house and to enjoy the comings and goings. Hugh was, of course, particularly pleased when his 'scientific children and grandchildren' came to visit and Mary and he were always there for thoughtful advice and support.
The co-workers and colleagues the Blaschkos entertained and looked after came from all over the world. It was therefore natural that they in turn were invited and travelled to many places, for conferences, for lecturing and to receive honours. Hugh also maintained close connexions with his old Department which in 1990 moved into a tailor-made new building in Mansfield Road. His Park Town home was on one side of the University Parks and the old and new Pharmacology Departments were on the other. So, unless the weather was really bad even by Oxford standards, Hugh took twice daily walks across the Parks. Presumably this gentle but regular exercise was good for him for, apart from the three episodes of tuberculosis in the first half of his life, and a liability to colds in winter, Hugh, carefully looked after by Mary, appeared remarkably well throughout his long life. Although clearly frailer and more stooping with age, the soundness of his constitution came through again when, aged 91, he survived a major operation for an almost symptomless abdominal emergency. He recovered sufficiently to enjoy his home, his friends and his interests for over two more years. He died peacefully from an internal haemorrhage on 18 April 1993. On 22 May there was a very moving commemoration in the Friends Meeting House.
H u g h t h e p e r s o n Hugh Blaschko had the total integrity which is a sine qua non requirement of scientists in their work. It was impossible not to trust him and this gave a feeling of safety to his young people who were starting out in research and insecure about their abilities and their future. To them he also transmitted his enthusiasm. He was devoted to science, not only for its intellectual and practical challenges but also because of its effects on society: its inherent universality, its progress from uncertainty to certainty to uncertainty and its incompatibility with dogmas. Agreeing with Max Bom that 'the greatest blessing that modem science has brought us is a loosening of thinking (Lockerung des Denkens)', Hugh continued in the scientific-humanistic tradition of his father.
Hugh notably lacked the competitive spirit that drives commerce and is not unknown in science. On one occasion he was told that a well known colleague had begun working on a problem identical to his own, and one of his young people said they would have to rush the next few months' experiments to get into print first. Hugh's reply was, 'He is a dedicated, reliable worker of great competence. If he's doing the work he'll find the answer for us. So let's not waste time and resources on the same problem. There is so much else to do. Let's work on other problems which are equally or possibly more important.' It could never occur to Hugh to benefit himself at the expense of someone else. If he came across some piece of scientific information or had some bright idea that he thought might be useful to someone, he would immediately communicate it to that person. Hugh's work was driven by insatiable curiosity. It never left him because almost to the end of his life he came regularly to departmental seminars to hear about the latest research findings. The last seminar he attended was only three weeks before he died. After listening to two research students present their work he commented, 'I didn't understand everything about the ion channels but I liked the project; and didn't the girl do hers well. ' The liveliness of Hugh's mind came out well in his talks to the Physiological Society. They were a pleasure to listen to not only because he related the findings of the moment to much wider settings but also because of the exciting way in which he talked; unable to stand still he conveyed his excitement by walking ceaselessly across the platform from side to side, sometimes followed by a distraught chairman trying to thank the speaker.
One of Hugh's strengths was an astonishing memory. This was behind his extraordinary knowledge of scientific and non-scientific matters, as well as all kinds of fascinating trivia. All who worked with him recall his trick -only it wasn't a trick -of saying: 'Now let me see, that paper is in the Biochemical Journal of ...' whereupon he would haul down a 12-year-old volume and open it at the right page. Some three years before Hugh died he complained to a friend that his memory was failing. Asked why he thought so he sadly replied that he was having to write down telephone numbers! Despite this complaint there was little evidence that ageing seriously impaired even his short-term memory, nor indeed his capacity for assimilating information. Sitting in lectures he had the habit of closing his eyes, giving the impression that he was asleep. But at the end of the lecture he was able to repeat almost everything that had been said and to ask entirely pertinent questions. He said that closing his eyes helped him to concentrate.
In spite of the inevitable setbacks in a long life, including a serious illness and the change of country, Hugh Blaschko appeared to all a completely contented man. Even under extreme bodily stress, Hugh retained his internal calm. When desperately ill in hospital he spoke to his visitors mostly about the other sick people he was with, and said that he wouldn't have missed this experience for anything. Throughout his life his face conveyed a wonderful blend of intelligence, kindliness, sensibility and humour. In his relationships he was open-minded, thoughtful and low-key. He combined strongly held opinions with gentle ways of expressing them. Finding good in everyone, his comments were invariable generous but by no means blind to the quaint, the comic or the absurd. Together with an impish sense of humour and total lack of conceit, all this made Hugh a most delightful person to be with.
Hugh Blaschko will be remembered as one of the scientists whose work improved the outlook in diseases as diverse as hypertension, depression, schizophrenia and Parkinson's disease. This is an extraordinary achievement. The following is a list of selected reviews. The complete bibliography appears on the accompanying microfiche. A photocopy is available from the Royal Society Library at cost.
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